CXCL10 and melanoma: Barreira da Silva and colleagues have shown that DPP-4 inhibition preserved the active form of chemokine CXCL10, which enhanced T-cell accumulation and immunity, resulting in diminished growth of murine melanoma and colon cancer (27).